Approvals/NMPA/Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol

Approved

化学药品

Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol

ASTRAZENECA AB🇨🇳 National Medical Products Administration

Approval Id: 8fOMxsnd4md
Approval Number: 国药准字HJ20190063
Generic Name: 布地格福吸入气雾剂
Generic Name En: Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol
Drug Type: 化学药品
Dosage Form: 气雾剂
Strength: 每瓶120揿，每揿含布地奈德160μg、格隆铵7.2μg和富马酸福莫特罗4.8μg
Reg Date: 2024-09-02
Expired Date: 2029-09-01
Company Name: ASTRAZENECA AB
Production Company Name: ASTRAZENECA DUNKERQUE PRODUCTION
Company Detail Path: /organization/astrazeneca-ab
Production Company Detail Path: /organization/astrazeneca-dunkerque-production

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 2, 2024

Approval ID

8fOMxsnd4md

Type

化学药品